SHPA welcomes the Federal Labor Party’s announcement pledging to reduce the general patient Pharmaceutical Benefits Scheme (PBS) co payment from $42.50 to $30 from 1 January 2023, and their bipartisan support to improve medicines affordability and access for Australians, guaranteeing Australians more affordable medicines from 2023.
SHPA welcomes the joint announcement from Prime Minister, the Hon. Scott Morrison MP and Minister for Health and Aged Care, the Hon. Greg Hunt MP to reduce the general patient PBS co-payment from $42.50 to $32.50 from 1 January 2023 and calls for bipartisan support on this announcement to ensure the best access to medicines is guaranteed for all Australians after the Federal election.
SHPA welcomes the Federal Government’s pre-election budget centred on easing cost-of-living pressures, while cautioning announced expenditure in hospitals and pandemic preparedness will have limited impact without developing Australia's current and future workforce of Hospital Pharmacists.
SHPA has welcomed yesterday’s announcement by the Federal Minister for Health and Aged Care, the Hon. Greg Hunt MP on the listing of molnupiravir (Lagevrio) on the Pharmaceutical Benefits Scheme (PBS).
